Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria
Won-Sun Choi, Eun-Soo Lim, Ga-Young Ban, Ji-Hye Kim, Yoo-Seob Shin, Hae-Sim Park, Young-Min Ye
Korean J Intern Med. 2018;33(1):185-192.   Published online 2016 Jun 1     DOI: https://doi.org/10.3904/kjim.2015.195
Citations to this article as recorded by Crossref logo
Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data
P. Staubach, M. Metz, N. Chapman-Rothe, C. Sieder, M. Bräutigam, M. Maurer, K. Weller
Allergy.2018; 73(3): 576.     CrossRef
Educational level and job status are the most important factors affecting compliance with oral antihistamine therapy for patients with chronic urticaria
Neslihan Akdogan, Pinar Incel-Uysal, Ayşe Oktem, Yildiz Hayran, Basak Yalcin
Journal of Dermatological Treatment.2018; : 1.     CrossRef
Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study
M.N. Ghazanfar, J.G. Holm, S.F. Thomsen
Journal of the European Academy of Dermatology and.2018; 32(10): 1761.     CrossRef
Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria
James L. Zazzali, Allen Kaplan, Marcus Maurer, Karina Raimundo, Benjamin Trzaskoma, Evgeniya N. Antonova, Karin E. Rosén
Annals of Allergy, Asthma & Immunology.2017; 118(4): 524.     CrossRef